We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Pathology

Image: The FDA clearances cover Aperio iQC DX software, the Aperio GT 180 DX scanner, and enhanced Aperio GT 450 DX capabilities, giving labs more flexibility to scale digital pathology while maintaining speed and image quality (Photo courtesy of Leica Biosystems)

AI Tool Identifies Slide Artifacts to Speed Digital Pathology Diagnosis

An FDA-cleared AI QC system flags six image artifacts during scanning, reducing rescans and speeding consistent image delivery. More...
13 Aug 2026
Image: Through the PCCP, Proscia gains a more efficient pathway to expand Concentriq AP-Dx interoperability while maintaining regulatory oversight (Photo courtesy of Proscia)

FDA-Cleared Digital Pathology Platform Expands Interoperability for Primary Diagnosis

A newly cleared digital pathology system expands interoperability and cloud support for primary diagnosis. More...
10 Aug 2026
image Credit: iStock

AI Pathology Tool Predicts Relapse Risk in Stage II Colorectal Cancer

An AI approach using routine pathology data predicts relapse risk in stage-two bowel cancer to focus monitoring and adjuvant care. More...
30 Jul 2026
Image: The AI analyzes digitized histology to identify tumor regions, distinguish cancerous from healthy cells, and quantify tumor cell density (Image Credit: Shutterstock)

AI Pathology Tool Stratifies Rectal Cancer to Guide Chemoradiotherapy

An AI approach measured tumor cell density in rectal cancer biopsies to predict benefit from irinotecan plus chemoradiotherapy. More...
28 Jul 2026
Image: Agilent’s PD-L1 IHC 22C3 pharmDx has received EU certification as a companion diagnostic to identify PD-L1–positive ovarian, fallopian tube, or primary peritoneal carcinoma patients eligible for KEYTRUDA (Photo courtesy of Agilent)

PD-L1 Assay Guides Pembrolizumab Eligibility in Ovarian, Fallopian Tube, and Peritoneal Cancers

An EU‑certified companion diagnostic extends PD‑L1 testing to ovarian and related cancers to guide pembrolizumab eligibility. More...
27 Jul 2026
Image: Covering biopsies and excisions, the breast suite provides a fully IVDR-certified, end-to-end workflow across H&E, HER2, ER, PR, and Ki67-stained whole-slide images (Photo Courtesy of Ibex Medical Analytics)

AI Digital Pathology Platform Standardizes IHC Scoring in Breast Cancer

An AI system gains CE-IVDR for breast IHC, standardizing ER/PR/Ki67 and HER2 scoring to improve precision and workflow efficiency. More...
24 Jul 2026
Multiplex immunofluorescent (left) and H&E-stained (right) breast tumor samples illustrating high versus low Base Topology Scores. Higher topology scores reflect more organized tissue architecture, while lower scores indicate greater structural disorganization. By quantitatively measuring these structural differences, the researchers developed biomarkers that predicted patient outcomes more accurately than many traditional approaches. (Photo courtesy of Columbia University Irving Medical Center)

Digital Pathology Tool Predicts Breast Cancer Outcomes and Therapy Response

A topology-based approach quantifies tumor architecture to improve breast cancer prognosis and predict therapy response. More...
22 Jul 2026
Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Prefilled Tubes
Prefilled 5.0ml Tubes
Food Allergy Screening ELISA Kit
Allerquant 14G B ELISA


The Pathology channel details advances in the field of Surgical Pathology and all its subspecialties, including Cytopathology and its subspecialties.
Copyright © 2000-2026 Globetech Media. All rights reserved.